A Wodnar-Filipowicz

987 total citations
34 papers, 828 citations indexed

About

A Wodnar-Filipowicz is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, A Wodnar-Filipowicz has authored 34 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 11 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in A Wodnar-Filipowicz's work include Hematopoietic Stem Cell Transplantation (18 papers), Mesenchymal stem cell research (8 papers) and Acute Myeloid Leukemia Research (7 papers). A Wodnar-Filipowicz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Mesenchymal stem cell research (8 papers) and Acute Myeloid Leukemia Research (7 papers). A Wodnar-Filipowicz collaborates with scholars based in Switzerland, United States and Poland. A Wodnar-Filipowicz's co-authors include Christoph Moroni, C Nissen, André Tichelli, B Speck, Aloïs Gratwohl, C.Y. Lai, A Gratwohl, Christian P. Kalberer, C. Nissen and SD Lyman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

A Wodnar-Filipowicz

33 papers receiving 797 citations

Peers

A Wodnar-Filipowicz

HEMAT

IMMUN

ONCOL

GENET

Tomoaki Kuwaki Japan

Birgit M.M. van den Berg Netherlands

Marian Seto United States

Yun‐Feng Piao China

H G Drexler Germany

Sara J. Dawson United Kingdom

Judith Gan Israel

Y Takihara Japan

JW Schrader Canada

K. Vehmeyer Germany

Tomoaki Kuwaki Japan

A Wodnar-Filipowicz

309 ×0.9

HEMAT

417 ×1.4

IMMUN

359 ×1.2

246 ×1.4

ONCOL

86 ×0.7

GENET

Citations per year, relative to A Wodnar-Filipowicz A Wodnar-Filipowicz (= 1×) peers Tomoaki Kuwaki

Countries citing papers authored by A Wodnar-Filipowicz

Since Specialization

Citations

This map shows the geographic impact of A Wodnar-Filipowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Wodnar-Filipowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Wodnar-Filipowicz more than expected).

Fields of papers citing papers by A Wodnar-Filipowicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Wodnar-Filipowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Wodnar-Filipowicz. The network helps show where A Wodnar-Filipowicz may publish in the future.

Co-authorship network of co-authors of A Wodnar-Filipowicz

This figure shows the co-authorship network connecting the top 25 collaborators of A Wodnar-Filipowicz. A scholar is included among the top collaborators of A Wodnar-Filipowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Wodnar-Filipowicz. A Wodnar-Filipowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siegler, Uwe, et al.. (2009). Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells. Haematologica. 94(11). 1590–1594. 25 indexed citations

Wodnar-Filipowicz, A & Christian P. Kalberer. (2006). Function of natural killer cells in immune defence against human leukemia. Swiss Medical Weekly. 136(2324). 359–364. 10 indexed citations

Siegler, Uwe, et al.. (2005). Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice. Leukemia. 19(12). 2215–2222. 47 indexed citations

Nissen, C, Daniel Surbek, Wolfgang Holzgreve, et al.. (2001). Fetal Hematopoietic Stem Cells: In Vitro Expansion and Transduction Using Lentiviral Vectors. PubMed. 123–144. 1 indexed citations

Hoffmann, Till, Gennaro De Libero, Marco Colonna, et al.. (2000). Natural killer‐type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T‐cell type. British Journal of Haematology. 110(3). 525–537. 32 indexed citations

Surbek, Daniel, Wolfgang Holzgreve, Christian Steinmann, et al.. (2000). Preterm birth and the availability of cord blood for HPC transplantation. Transfusion. 40(7). 817–820. 22 indexed citations

Tichelli, André, et al.. (1999). Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation. Bone Marrow Transplantation. 23(11). 1205–1207. 14 indexed citations

Tichelli, André, Daniel Surbek, Lisa S. St. John, et al.. (1998). [Establishing an umbilical cord blood bank for unrelated allogenic stem cell transplantation].. PubMed. 128(42). 1598–601. 1 indexed citations

Nissen, C, et al.. (1998). The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.. PubMed. 26(5). 365–73. 27 indexed citations

10.

Chklovskaia, Elena, Wendy Jansen, C Nissen, et al.. (1997). Flt3 ligand is prestored in t-lymphocytes and is released in response to chemotherapy-induced stem cell depletion. Experimental Hematology. 25(8). 2 indexed citations

11.

Wodnar-Filipowicz, A, et al.. (1997). Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.. PubMed. 25(7). 573–81. 7 indexed citations

12.

Nissen, C, et al.. (1996). Deficiency of CD34+c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment. American Journal of Hematology. 52(4). 264–274. 37 indexed citations

13.

Wodnar-Filipowicz, A, SD Lyman, A Gratwohl, et al.. (1996). Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood. 88(12). 4493–4499. 98 indexed citations

14.

Nissen, C, et al.. (1995). Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse. European Journal Of Haematology. 55(4). 255–261. 15 indexed citations

15.

Nissen, C, et al.. (1995). Stem‐cell factor in aplastic anemia: in vitro expression in bone marrow stroma and fibroblast cultures. European Journal Of Haematology. 54(4). 262–269. 15 indexed citations

16.

Moroni, Christoph, et al.. (1989). Multistage Mastocytoma Model Characterized by Autocrine IL-3 Production. Hämatologie und Bluttransfusion. 32. 407–410. 1 indexed citations

17.

Wodnar-Filipowicz, A, Josef Jiricny, M. Fopp, et al.. (1988). Mutation analysis of the N‐ras proto‐oncogene in active and remission phase of human acute leukemias. International Journal of Cancer. 41(1). 59–64. 43 indexed citations

18.

Wodnar-Filipowicz, A, et al.. (1987). Amino Acid Substitution at Position 13 of the N-ras Gene in a Non-Hodgkin’s Lymphoma Patient. Hämatologie und Bluttransfusion. 31. 172–174. 1 indexed citations

19.

Filipowicz, Witold, A Wodnar-Filipowicz, & Przemysław Szafrański. (1976). Activity of methoxyamine-modified f2 RNA in initiation and elongation steps of protein synthesis.. PubMed. 23(2-3). 243–59. 1 indexed citations

20.

Wodnar-Filipowicz, A, Witold Filipowicz, & Przemysław Szafrański. (1975). Preparation and characteristics of the structure of methoxyamine-modified f2 RNA.. PubMed. 22(1). 11–24. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact